Influence of the biogenic amine tyramine on ethanol-induced behaviors in Drosophila.
The biogenic amine tyramine has been implicated in drug-induced behavior. The Drosophila inactive mutant is characterized by reduced tyramine and octopamine levels and is defective in cocaine sensitization. To test whether there is an overlap in the use of the amine neurotransmitter system in ethanol- and cocaine-induced behaviors, mutant analyses were extended to the phenotypic characterization of inactive and other mutants effecting the tyramine and octopamine neurotransmitter system. The inactive mutant displays increased ethanol sensitivity and is impaired in the initial startle response upon ethanol application. Furthermore, this mutant fails to regulate its alcohol-induced hyperactivity properly. In contrast to the defects seen after cocaine application, inactive mutants develop normal ethanol tolerance and sensitize to the locomotor activating effect of ethanol. The tyramine-beta-hydroxylase mutant (TbetaH) with increased tyramine and depleted octopamine levels displays normal ethanol sensitivity, a startle repression, and hyperactivates more in response to ethanol. In addition, TbetaH mutants fail to develop a tolerance to the hyperactivating effect of ethanol. Ethanol-induced sensitization does not seem to be impaired in either mutant, suggesting that tyramine is not required for this process. The comparative analysis of the phenotypes associated with inactive and TbetaH mutants suggests that the fine tuning of ethanol-induced hyperactivity can be correlated with different tyramine levels. Defects in other aspects of ethanol-induced behaviors might be due to different molecules or mechanisms.
Scholz
Henrike
H
Lehrstuhl für Genetik und Neurobiologie, Biozentrum, Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany. henrike.scholz@biozentrum.uni-wuerzburg.de
D000818:Animals; D001679:Biogenic Amines / Q000502:physiology; D004330:Drosophila / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D029721:Drosophila Proteins / Q000235:genetics; D000431:Ethanol / Q000494:pharmacology*; D007473:Ion Channels / Q000235:genetics; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009154:Mutation; D013216:Reflex, Startle / Q000187:drug effects* / Q000502:physiology; D014439:Tyramine / Q000096:biosynthesis / Q000502:physiology*
D001679:Biogenic Amines; D029721:Drosophila Proteins; C494780:IAV protein, Drosophila; D007473:Ion Channels; D000431:Ethanol; D006899:Mixed Function Oxygenases; C023205:tyramine beta-hydroxylase; D014439:Tyramine